SG10201908987VA - Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein - Google Patents
Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted thereinInfo
- Publication number
- SG10201908987VA SG10201908987VA SG10201908987VA SG10201908987VA SG 10201908987V A SG10201908987V A SG 10201908987VA SG 10201908987V A SG10201908987V A SG 10201908987VA SG 10201908987V A SG10201908987V A SG 10201908987VA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- human animal
- nog
- human
- searching
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 12
- 201000011510 cancer Diseases 0.000 title abstract 12
- 238000010171 animal model Methods 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 238000012216 screening Methods 0.000 title abstract 2
- 230000008520 organization Effects 0.000 abstract 3
- 230000007170 pathology Effects 0.000 abstract 3
- 230000004071 biological effect Effects 0.000 abstract 2
- 241000699670 Mus sp. Species 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000003278 mimic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Environmental Sciences (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009295426 | 2009-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201908987VA true SG10201908987VA (en) | 2019-11-28 |
Family
ID=44195826
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012047213A SG181938A1 (en) | 2009-12-25 | 2010-12-24 | Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
SG10201908987V SG10201908987VA (en) | 2009-12-25 | 2010-12-24 | Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012047213A SG181938A1 (en) | 2009-12-25 | 2010-12-24 | Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
Country Status (7)
Country | Link |
---|---|
US (2) | US11536713B2 (zh) |
EP (2) | EP2517555A4 (zh) |
JP (1) | JP5808054B2 (zh) |
CN (1) | CN102821600B (zh) |
HK (1) | HK1177664A1 (zh) |
SG (2) | SG181938A1 (zh) |
WO (1) | WO2011078301A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2517555A4 (en) | 2009-12-25 | 2014-09-24 | Chugai Pharmaceutical Co Ltd | METHOD OF SEARCHING AND SCREENING AN ANTICANCER AGENT TARGET USING A NON-HUMAN ANIMAL MODEL HAVING BEEN TRANSPORTED A LINE OF CANCER CELLS ESTABLISHED ON NOG |
US9778264B2 (en) | 2010-09-03 | 2017-10-03 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
US9945842B2 (en) | 2010-09-03 | 2018-04-17 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
SG196836A1 (en) | 2010-10-06 | 2014-02-13 | Pharmalogicals Res Pte Ltd | Cancer stem cell population and method for production thereof |
EP2749641B1 (en) * | 2011-09-07 | 2021-06-02 | Chugai Seiyaku Kabushiki Kaisha | Cancer stem cell isolation |
JP6291254B2 (ja) | 2011-10-28 | 2018-03-14 | 中外製薬株式会社 | 癌幹細胞特異的分子 |
JP2014033626A (ja) * | 2012-08-08 | 2014-02-24 | Juntendo | ヒト癌上皮細胞の遠隔転移のモデルマウス作出方法 |
JP2015057974A (ja) * | 2013-09-18 | 2015-03-30 | 学校法人順天堂 | 患者原発性大腸癌の個別化転移モデルマウスの作製方法 |
WO2016205523A1 (en) * | 2015-06-16 | 2016-12-22 | The Jackson Laboratory | Genetically modified non-human animals and methods relating to complement dependent cytotoxicity |
EP3332814A4 (en) * | 2015-08-03 | 2018-07-25 | FUJIFILM Corporation | Cell structure, non-human model animal, method for producing non-human model animal, and method for evaluating test substance |
CN105296430B (zh) * | 2015-09-29 | 2018-08-17 | 浙江大学 | 一种人类结肠癌细胞系dxh-1及其应用 |
CN110998320B (zh) * | 2017-08-21 | 2024-04-09 | 凸版印刷株式会社 | 抗癌效果的评价方法及癌症免疫疗法的有效性预测方法 |
CN111670247B (zh) * | 2017-12-08 | 2024-01-05 | 京诊断株式会社 | 制备癌球状体的方法和选择结直肠癌患者的方法 |
CN108977410B (zh) * | 2018-08-02 | 2023-04-25 | 郭世伟 | 中国人胰腺癌原位癌细胞系 |
CN112544567B (zh) * | 2019-09-10 | 2022-11-01 | 上海交通大学医学院附属仁济医院 | 髓母细胞瘤动物模型及其建立与应用 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573924A (en) | 1992-09-08 | 1996-11-12 | Immunex Corporation | CD27 ligand |
US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
US8044259B2 (en) | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
EP1338198B1 (en) | 2000-12-01 | 2007-11-28 | Central Institute For Experimental Animals | Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse |
WO2003104401A2 (en) | 2002-06-05 | 2003-12-18 | Avalon Pharmaceuticals, Inc. | Cancer-linked gene as target for chemotherapy |
US20070053884A1 (en) | 2003-05-16 | 2007-03-08 | Kyowa Hakko Kogyo Co., Ltd | Novel adult tissue-derived stem cell and use thereof |
CA2447400A1 (en) | 2003-09-12 | 2005-03-12 | The Hospital For Sick Children | Brain tumor stem cells |
AU2004280064A1 (en) | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Genomically modified cell neutralized to serum-free system |
JP2005206508A (ja) | 2004-01-22 | 2005-08-04 | Chemo Sero Therapeut Res Inst | 悪性腫瘍細胞増殖抑制抗体 |
CN1980957A (zh) | 2004-03-23 | 2007-06-13 | 比奥根艾迪克Ma公司 | 受体偶联剂及其治疗用途 |
US20080268476A1 (en) | 2004-05-12 | 2008-10-30 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nectin 4 (N4) as a Marker for Cancer Prognosis |
US20080152700A1 (en) * | 2004-06-01 | 2008-06-26 | Reza Sheikhnejad | Methods and compositions for the inhibition of gene expression |
US20090214517A1 (en) | 2004-07-27 | 2009-08-27 | Justin Wong | Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease |
JP2008514205A (ja) | 2004-09-29 | 2008-05-08 | 財団法人実験動物中央研究所 | Nogマウスを用いた高転移性細胞株の樹立 |
WO2006051405A2 (en) | 2004-11-12 | 2006-05-18 | Cambridge University Technical Services Ltd. | Methods and means related to cancer stem cells |
JPWO2006051984A1 (ja) | 2004-11-15 | 2008-05-29 | キリンファーマ株式会社 | 癌細胞の転移抑制方法およびそのために使用する医薬組成物 |
CA2605507C (en) | 2005-04-19 | 2016-06-28 | Seattle Genetics, Inc. | Humanized anti-cd70 binding agents and uses thereof |
AU2006259583A1 (en) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
CA2657886A1 (en) | 2005-07-26 | 2007-02-01 | Procure Therapeutics Limited | Stem cell markers |
JP2009509510A (ja) | 2005-09-26 | 2009-03-12 | メダレックス インコーポレーティッド | Cd70に対するヒトモノクローナル抗体 |
AU2006308847C1 (en) | 2005-10-31 | 2012-05-10 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
US20070220621A1 (en) | 2005-10-31 | 2007-09-20 | Clarke Michael F | Genetic characterization and prognostic significance of cancer stem cells in cancer |
CA2631931C (en) | 2005-12-01 | 2014-04-29 | Pronai Therapeutics, Inc. | Cancer therapies and pharmaceutical compositions used therein |
EP1792979A1 (en) | 2005-12-01 | 2007-06-06 | Stiftung Caesar Center of Advanced European Studies and Research | Cell culture system for the enrichment and expansion of stem cells |
WO2007132883A1 (ja) * | 2006-05-17 | 2007-11-22 | Yokohama City University | 肝臓癌の鑑別、疾患ステージの判定又は予後の予測方法及びキット |
JP2009539374A (ja) | 2006-06-06 | 2009-11-19 | ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション | 腫瘍性幹細胞が富化された組成物及びそれを含む方法 |
US8557584B2 (en) | 2006-08-11 | 2013-10-15 | Ao-Forschungsinstitut Davos | Preparing a homogenous population of stem cells committed to differentiated to a specific cell type |
EP2074144A4 (en) | 2006-09-05 | 2011-03-16 | Medarex Inc | ANTIBODIES TO BONE MORPHOGENIC PROTEINS AND RECEPTORS THEREFOR AND METHOD FOR THEIR USE |
WO2008033393A2 (en) | 2006-09-11 | 2008-03-20 | University Of Florida | Isolation, expansion and uses of tumor stem cells |
GB2442059A (en) | 2006-09-19 | 2008-03-26 | Ist Superiore Sanita | Test for cancer of the gastrointestinal tract |
AU2007312367B2 (en) | 2006-10-12 | 2012-09-06 | Chugai Seiyaku Kabushiki Kaisha | Diagnosis and treatment of cancer using anti-EREG antibody |
JP2008102012A (ja) | 2006-10-19 | 2008-05-01 | Kanazawa Univ | 癌幹細胞の同定および単離方法 |
EP2109668A4 (en) | 2007-01-22 | 2011-10-05 | Macrogenics West Inc | HUMAN CANCER STEM CELLS |
JP2008182912A (ja) | 2007-01-29 | 2008-08-14 | Nippon Kayaku Co Ltd | 癌幹細胞の培養方法、および癌幹細胞 |
BRPI0811857A2 (pt) | 2007-05-14 | 2014-10-21 | Biogen Idec Inc | Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados. |
WO2008149803A1 (ja) | 2007-06-06 | 2008-12-11 | The University Of Tokyo | 表面抗原マーカーを用いた急性リンパ性白血病における癌幹細胞の分離同定方法 |
ES2553169T5 (es) | 2007-07-02 | 2023-11-30 | Oncomed Pharm Inc | Composiciones y métodos para el tratamiento y el diagnóstico del cáncer |
WO2009023194A2 (en) | 2007-08-10 | 2009-02-19 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
EP2022848A1 (en) | 2007-08-10 | 2009-02-11 | Hubrecht Institut | A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
GB2465940A (en) | 2007-10-01 | 2010-06-09 | Hospital For Sick Children | Neural tumor stem cells and methods of use thereof |
WO2009064301A1 (en) | 2007-11-15 | 2009-05-22 | The Johns Hopkins University | Methods for detecting and monitoring circulating cancer stem cells |
EP2271941B1 (en) * | 2008-03-07 | 2012-08-08 | OSI Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
CN102076865B (zh) | 2008-05-02 | 2016-03-16 | 西雅图基因公司 | 用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物 |
WO2010009121A2 (en) | 2008-07-15 | 2010-01-21 | University Of Florida Research Foundation, Inc. | Colon stem cells associated with colitis and colorectal cancer and methods of use |
WO2010016766A2 (en) | 2008-08-08 | 2010-02-11 | Koninklijke Nederlandse Akademie Van Wetenschappen | Antibodies recognizing endogenous human lgr5 and/or lgr6 |
EP2373794A4 (en) | 2008-12-12 | 2012-09-05 | Oncotherapy Science Inc | NECTINE-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS OF CANCER |
EA201101241A1 (ru) | 2009-03-06 | 2012-04-30 | Калобайос Фармасьютиклз, Инк. | Лечение лейкозов и хронических миелопролиферативных болезней антителами к ерна3 |
AU2010231575B2 (en) | 2009-03-30 | 2013-09-12 | Edimer Biotech S.A. | Preparation of isolated agonist anti-EDAR monoclonal antibodies |
MA33323B1 (fr) | 2009-04-20 | 2012-06-01 | Genentech Inc | Thérapie adjuvante de cancer |
TW201105347A (en) | 2009-04-28 | 2011-02-16 | Chugai Pharmaceutical Co Ltd | Pharmaceutical compositions for maintenance therapy containing HLA class I-recognizing antibody as the active ingredient |
EP2436397B1 (en) | 2009-05-29 | 2017-05-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition containing antagonist of egf family ligand as component |
WO2011027308A1 (en) | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
EP2517555A4 (en) | 2009-12-25 | 2014-09-24 | Chugai Pharmaceutical Co Ltd | METHOD OF SEARCHING AND SCREENING AN ANTICANCER AGENT TARGET USING A NON-HUMAN ANIMAL MODEL HAVING BEEN TRANSPORTED A LINE OF CANCER CELLS ESTABLISHED ON NOG |
US9217032B2 (en) | 2010-01-08 | 2015-12-22 | Les Laboratoires Servier | Methods for treating colorectal cancer |
SG196836A1 (en) | 2010-10-06 | 2014-02-13 | Pharmalogicals Res Pte Ltd | Cancer stem cell population and method for production thereof |
EP2749641B1 (en) | 2011-09-07 | 2021-06-02 | Chugai Seiyaku Kabushiki Kaisha | Cancer stem cell isolation |
JP6291254B2 (ja) | 2011-10-28 | 2018-03-14 | 中外製薬株式会社 | 癌幹細胞特異的分子 |
-
2010
- 2010-12-24 EP EP10839531.0A patent/EP2517555A4/en active Pending
- 2010-12-24 SG SG2012047213A patent/SG181938A1/en unknown
- 2010-12-24 SG SG10201908987V patent/SG10201908987VA/en unknown
- 2010-12-24 JP JP2011547619A patent/JP5808054B2/ja active Active
- 2010-12-24 US US13/519,059 patent/US11536713B2/en active Active
- 2010-12-24 EP EP23152521.3A patent/EP4190149A1/en active Pending
- 2010-12-24 WO PCT/JP2010/073266 patent/WO2011078301A1/ja active Application Filing
- 2010-12-24 CN CN201080064764.7A patent/CN102821600B/zh active Active
-
2013
- 2013-04-18 HK HK13104740.0A patent/HK1177664A1/zh unknown
-
2022
- 2022-11-22 US US17/992,032 patent/US20230085803A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4190149A1 (en) | 2023-06-07 |
EP2517555A1 (en) | 2012-10-31 |
EP2517555A4 (en) | 2014-09-24 |
US20230085803A1 (en) | 2023-03-23 |
US11536713B2 (en) | 2022-12-27 |
WO2011078301A1 (ja) | 2011-06-30 |
CN102821600B (zh) | 2016-01-20 |
SG181938A1 (en) | 2012-07-30 |
US20130019327A1 (en) | 2013-01-17 |
CN102821600A (zh) | 2012-12-12 |
JP5808054B2 (ja) | 2015-11-10 |
JPWO2011078301A1 (ja) | 2013-05-09 |
HK1177664A1 (zh) | 2013-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201908987VA (en) | Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein | |
GB2434157A (en) | Platelets from stem cells | |
IN2015DN00017A (zh) | ||
BR112017008251A2 (pt) | usos de um tecido de um porco transgênico que compreende um gene a(1,3) galactosiltransferase, cmah e ß4galnt2 interrompido e de um produto relacionado com a pele, métodos para preparação de um material de transplante para xenoenxerto, para produção de um composto de interesse e para produzir um reagente de cultura de células, e, reagente de cultura de células | |
EP3257943A3 (en) | Methods and vectors for cell immortalisation | |
WO2011149762A3 (en) | Method of nociceptor differentiation of human embryonic stem cells and uses thereof | |
MX2012004881A (es) | Metodos para reprogramar células y sus usos. | |
EA201490796A1 (ru) | Дофамининовые (да) нейроны среднего мозга для трансплантации | |
NZ596162A (en) | Pharmaceutical composition for the treatment of heart diseases | |
MX2012000899A (es) | Diferenciacion de celulas madre embrionarias humanas. | |
MX355077B (es) | Diferenciacion de celulas madre embrionarias humanas. | |
ES2523998T3 (es) | Método de aislamiento de citoblastos dérmicos | |
CL2012002882A1 (es) | Compuestos derivados de 5,7- sustituido -imidazol [1,2-c] pirimidinas, inhibidores de jak-quinasa; proceso de preparacion; composicion farmaceutica; y su uso para tratar una enfermedad autoinmunitaria o inflamatoria, el rechazo de transplante de organos, tejidos o celulas en un mamifero. | |
JP2013535961A5 (zh) | ||
WO2008055224A3 (en) | Lithium stimulation of cord blood stem cell proliferation and growth factor production | |
MX2019009549A (es) | Metodo de injerto de celulas a partir de tejidos solidos. | |
MX2019015321A (es) | Composiciones tridimensionales de tejido y métodos de uso. | |
WO2013005110A3 (en) | Synthetic scaffolds and organ and tissue transplantation | |
MX2013002405A (es) | Diferenciacion de celulas madre embrionarias humanas. | |
MX2011008373A (es) | Procedimiento para la criopreservacion de celulas, construcciones celulares artificiales o ensamblajes de tejidos complejos tridimensionales. | |
SG11201804755VA (en) | Method for manufacturing tissue/organ by using blood cells | |
BR112014015342A8 (pt) | células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano | |
AU2010314984A8 (en) | Germline stem cell banking system | |
EA201101626A1 (ru) | Бактерии с высокоэффективным метаболизмом | |
NZ602751A (en) | Processing biomass |